As of 2024-12-12, the Relative Valuation of Neogenomics Inc (NEO) is (20.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.17 USD, the upside of Neogenomics Inc based on Relative Valuation is -210.2%.
The range of the Relative Valuation is (19.12) - (20.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.6x - 34.9x | 33.5x |
| Forward P/E multiples | 31.1x - 34.0x | 32.6x |
| Fair Price | (19.12) - (20.56) | (20.03) |
| Upside | -205.2% - -213.2% | -210.2% |
| Date | P/E |
| 2024-11-25 | -27.96 |
| 2024-11-22 | -27.07 |
| 2024-11-21 | -25.42 |
| 2024-11-20 | -25.37 |
| 2024-11-19 | -25.37 |
| 2024-11-18 | -24.79 |
| 2024-11-15 | -24.84 |
| 2024-11-14 | -26.08 |
| 2024-11-13 | -27.13 |
| 2024-11-12 | -26.97 |
| 2024-11-11 | -27.00 |
| 2024-11-08 | -26.04 |
| 2024-11-07 | -26.13 |
| 2024-11-06 | -25.53 |
| 2024-11-05 | -24.66 |
| 2024-11-04 | -23.35 |
| 2024-11-01 | -23.12 |
| 2024-10-31 | -22.44 |
| 2024-10-30 | -22.28 |
| 2024-10-29 | -22.33 |
| 2024-10-28 | -22.26 |
| 2024-10-25 | -21.58 |
| 2024-10-24 | -21.55 |
| 2024-10-23 | -21.58 |
| 2024-10-22 | -21.83 |
| 2024-10-21 | -21.68 |
| 2024-10-18 | -22.39 |
| 2024-10-17 | -22.29 |
| 2024-10-16 | -22.84 |
| 2024-10-15 | -23.17 |
| 2024-10-14 | -22.81 |
| 2024-10-11 | -22.34 |
| 2024-10-10 | -22.36 |
| 2024-10-09 | -21.47 |
| 2024-10-08 | -22.19 |
| 2024-10-07 | -22.76 |
| 2024-10-04 | -23.02 |
| 2024-10-03 | -23.32 |
| 2024-10-02 | -23.68 |
| 2024-10-01 | -22.81 |
| 2024-09-30 | -24.36 |
| 2024-09-27 | -23.95 |
| 2024-09-26 | -24.18 |
| 2024-09-25 | -24.70 |
| 2024-09-24 | -26.09 |
| 2024-09-23 | -26.09 |
| 2024-09-20 | -26.88 |
| 2024-09-19 | -27.22 |
| 2024-09-18 | -26.69 |
| 2024-09-17 | -26.90 |